North America Biopharmaceutical Contract Manufacturing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian)

No. of Pages: 130    |    Report Code: TIPRE00010242    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Biopharmaceutical Contract Manufacturing Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Biopharmaceutical Contract Manufacturing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Biopharmaceutical Contract Manufacturing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing demand for biologics and biosimilars production
  • 5.1.2 Rising outsourcing trends in pharmaceutical manufacturing
5.2 Market Opportunities
  • 5.2.1 Growth in demand for contract services in vaccine production
  • 5.2.2 Expansion in emerging markets for contract manufacturing services
5.3 Future Trends
  • 5.3.1 Shift towards more flexible and scalable manufacturing facilities
  • 5.3.2 Rise of biopharmaceutical collaborations and partnerships
5.4 Impact of Drivers and Restraints

6. North America Biopharmaceutical Contract Manufacturing Market Regional Analysis

6.1 North America Biopharmaceutical Contract Manufacturing Market Overview
6.2 North America Biopharmaceutical Contract Manufacturing Market Revenue 2019-2028 (US$ Million)
6.3 North America Biopharmaceutical Contract Manufacturing Market Forecast Analysis

7. North America Biopharmaceutical Contract Manufacturing Market Analysis – by Product

7.1 Biologics
  • 7.1.1 Overview
  • 7.1.2 Biologics: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Biosimilar
  • 7.2.1 Overview
  • 7.2.2 Biosimilar: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Biopharmaceutical Contract Manufacturing Market Analysis – by Service

8.1 Process Development
  • 8.1.1 Overview
  • 8.1.2 Process Development: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Fill and Finish Operation
  • 8.2.1 Overview
  • 8.2.2 Fill and Finish Operation: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Analytical and QC Studies
  • 8.3.1 Overview
  • 8.3.2 Analytical and QC Studies: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Packaging
  • 8.4.1 Overview
  • 8.4.2 Packaging: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Biopharmaceutical Contract Manufacturing Market Analysis – by Source

9.1 Mammalian
  • 9.1.1 Overview
  • 9.1.2 Packaging: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Microbial-Based Biologics/Non-Mammalian
  • 9.2.1 Overview
  • 9.2.2 Packaging: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Biopharmaceutical Contract Manufacturing Market – North America Analysis

10.1 North America
  • 10.1.1 North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
    • 10.1.1.1.3 US: North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
  • 10.1.1.2 Canada: North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
    • 10.1.1.2.3 Canada: North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
  • 10.1.1.3 Mexico : North America Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Service
    • 10.1.1.3.3 Mexico : North America Biopharmaceutical Contract Manufacturing Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Biopharmaceutical Contract Manufacturing Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AbbVie Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Ajinomoto Co. Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Boehringer Ingelheim International GmbH
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 General Electric Company
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Lonza
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 MERCK KGAA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Samsung Biologics
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 THERMO FISHER SCIENTIFIC INC
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 WUXI BIOLOGICS
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. AbbVie Inc.
  2. Ajinomoto Co. Inc
  3. Boehringer Ingelheim International GmbH
  4. General Electric Company
  5. Lonza
  6. MERCK KGAA
  7. Samsung Biologics
  8. THERMO FISHER SCIENTIFIC INC
  9. WUXI BIOLOGICS
north-america-biopharmaceutical-contract-manufacturing-market